CHICAGO, Oct 06, 2008 /PRNewswire via COMTEX/ Roundtable Conference will Spotlight Emerging Trends in Plastic Surgery
Leerink Swann, the leading healthcare investment banking firm, and the American Society of Plastic Surgeons (ASPS), the largest organization of board-certified plastic surgeons in the world, today announced they will co-host a roundtable program, "The Future of Plastic Surgery," during Plastic Surgery 2008 in Chicago.
The roundtable, being held on Monday, November 3, from 8:00 a.m. until 3:00 p.m., will feature panel discussions by senior management executives from more than 15 companies and key opinion leaders from ASPS membership. The panels will focus on emerging trends and advances in technologies in plastic surgery and their business impact. Participants will discuss advancements in minimally invasive procedures, dermal fillers and neurotoxins, and soft tissue regenerative products. Drs. Daniel Dubin and Jonathan Gertler from Leerink Swann will moderate the discussions.
"Leerink Swann is pleased to join forces with the ASPS, the premier organization in plastic surgery, to establish a forum at its' annual meeting that allows for the exchange of information and interaction between investors and emerging growth companies," said Jeff Leerink, Chairman and CEO, Leerink Swann. "Leerink Swann hosts a series of standalone roundtable events in a number of healthcare and life sciences sectors and these events are widely lauded as important venues for institutional investors, venture capitalists, hedge funds, bankers and healthcare companies. We are looking forward to a successful event with ASPS."
As the leading plastic surgery society, ASPS plays a critical role in advancing research in the specialty. ASPS is the leading source for news on the latest advances and techniques in plastic surgery.
"ASPS is thrilled to team up with Leerink Swann on this plastic surgery roundtable," said ASPS Executive Vice President Paul Pomerantz. "Leerink Swann's leadership position in healthcare investment banking and unparalleled knowledge of the healthcare investment community, make them the ideal partner for this new initiative at the 2008 ASPS annual meeting. We look forward to reaching out to the investment community to become their trusted industry resource in the plastic surgery and aesthetic categories."
Participating companies in the roundtable include, but are not limited to: Allergan, Inc. (NYSE: AGN); Coapt Systems, Inc.; Cynosure, Inc. (NASDAQ: CYNO); Eleme Medical; Intercytex (LSE: ICX); Kythera Biopharmaceuticals, Inc.; LifeCell Corporation (subsidiary of Kinetic Concepts, Inc.); LipoSonix, Inc. (subsidiary of Medicis, Inc.); Medicis Pharmaceutical Corporation (NYSE: MRX); Organogenesis, Inc.; OrthoNeutrogena (a division of Johnson & Johnson); Revance Therapeutics, Inc.; TEI Biosciences; Ultra Shape; and Zeltiq Aesthetics.
The American Society of Plastic Surgeons is the largest organization of board-certified plastic surgeons in the world. Representing more than 6,700 physician members, the Society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 90 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. For more information, visit www.plasticsurgery.org.
About Leerink Swann
Leerink Swann is a healthcare-focused investment banking firm that provides equity research, corporate finance, strategic advisory, and asset management services for institutional, life sciences, and high-net-worth clients. Every year since 2001, Institutional Investor has named Leerink Swann "Best of the Boutiques" in several healthcare categories. Through its MEDACorp division, Leerink Swann provides biomedical-consulting services to the institutional investment community. With an internal team of experts and a dedicated external network of academic and community healthcare professionals, MEDACorp assesses the viability of cutting-edge medical technologies, thus giving decision makers the information they need to perform. Leerink Swann is a member of FINRA/SIPC. For more information, visit www.leerink.com.
SOURCE American Society of Plastic Surgeons